| Literature DB >> 27693654 |
Christelle Haziza1, Guillaume de La Bourdonnaye2, Sarah Merlet2, Muriel Benzimra2, Jacek Ancerewicz2, Andrea Donelli2, Gizelle Baker2, Patrick Picavet2, Frank Lüdicke2.
Abstract
Smoking conventional cigarettes (CCs) exposes smokers to harmful and potentially harmful constituents (HPHCs). The Tobacco Heating System 2.2 (THS 2.2), a candidate modified risk tobacco product, was developed to reduce or eliminate the formation of HPHCs, while preserving as much as possible the taste, sensory experience, nicotine delivery profile and ritual characteristics of CC. This randomized, controlled, open-label study in confinement for 5 day exposure aimed to demonstrate the reduction in exposure to selected HPHCs, to assess nicotine uptake and subjective effects, in participants switching to THS 2.2 (n = 80) compared to participants continuing smoking CCs (n = 40) and abstaining from smoking (n = 40). The subjects were randomized according to sex and daily CC consumption. The levels of biomarkers of exposure to HPHCs were significantly reduced in participants switching to THS 2.2, compared to CC use. More importantly, the magnitude of exposure reduction observed was close to that which was seen in participants who abstained from smoking for 5 days, while nicotine uptake was maintained. Reduction in urge-to-smoke was comparable between THS and CC groups, however THS 2.2 was slightly less satisfactory than CCs. The new, alternative tobacco product THS 2.2 was well tolerated. Copyright ÂEntities:
Keywords: Biomarkers of exposure; Harmful and potentially harmful constituents; Modified risk tobacco product; Randomized study; Reduced risk product; Smoking; Smoking abstinence; Tobacco heating system
Mesh:
Year: 2016 PMID: 27693654 DOI: 10.1016/j.yrtph.2016.09.014
Source DB: PubMed Journal: Regul Toxicol Pharmacol ISSN: 0273-2300 Impact factor: 3.271